Whole-genome analysis informs breast cancer response to aromatase inhibition.
Times cited: 572
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.
Breast Cancer Research and Treatment.
Times cited: 79
Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: A phase 2 randomized study.
JAMA - Journal of the American Medical Association.
Times cited: 169